RadicalCystectomyAsPrimaryTherapyforTGBladderCancer根治性膀胱切除术对于TG膀胱癌的主要疗法.pptxVIP

RadicalCystectomyAsPrimaryTherapyforTGBladderCancer根治性膀胱切除术对于TG膀胱癌的主要疗法.pptx

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
会计学1RadicalCystectomyAsPrimaryTherapyforTGBladderCancer根治性膀胱切除术对于TG膀胱癌的主要疗法 T1G3 Bladder Cancer “THE FACTS”Is a potentially lethal tumorThis is NOT a superficial tumorUnderstaging occurs frequentlyHigh recurrence rate and progression despite intravesical therapyPoor markers available to accurately identify high risk lesions Can be effectively CURED by early definitive surgery (radical cystectomy)第1页/共17页 BLADDER CANCER: TWO PATHWAYS OF PROGRESSIONNORMALUROTHELIUMTaTa9qDelRAST1T2-4N+/M+9pDel(INK4A)(Presti et al, Ca Res 91; Cordon-Cardo et al, JNCI 92; Dalbagni et al, Lancet 93; Sarkis et al, JNCI 93; Cairns et al, Science 94; Orlow et al, JNCI 95; Li et al, Am J Path 96; Rabbani et al, JNCI 99; McShane et al, Ca Res 2000; Hernando et al, Int J Ca 2001; Sanchez et al, Ca Res, 2002; Veltman et al Ca Res, 2003 )TisT1T2-4N+/M+TP53RB5qDel, 3pDel10qDel, 11pDel, 18qDel14qDel第2页/共17页 T1G3 Bladder Cancer Can we accurately detect this disease? Are we at risk for understaging?第3页/共17页 T1G3 And TIS Bladder Cancer Clinical UnderstagingAuthorP stage T1Amling (Duke), 199437%Soloway (Florida) 199436% (60% for Tis)Stein (USC) 200139%10 - 15% have positive nodes at cystectomy第4页/共17页 Risk Of Understaging Is Influenced By Presence Of Muscle In TUR SpecimenDutta, J Urol 166:490, 2001N=78Herr, HW J Urol 162:74, 1999A second TURBT required to identify extent of disease.第5页/共17页 T1G3 Bladder Cancer Outcome Of Understaged Patients Disease Specific OutcomesFreeman et al, Cancer, 1995179 patients (71% with T1 tumors)53% failed intravesical therapyUnderstaged lesions do significantly worseUnderstaged lesions WILL NOT respond to bladder sparing approaches第6页/共17页 Repeat TURBT May Help Reduce UnderstagingDalbagni et al, UROLOGY 2002第7页/共17页 T1G3 Bladder Cancer Natural History Recurrence and Progression RiskRecurrence RiskFollowing TURBT, 69-80% risk of recurrenceIntravesical immunotherapy can delay recurrence and progression, but long-term will not alter natural historyProgression Risk33

文档评论(0)

kuailelaifenxian + 关注
官方认证
文档贡献者

该用户很懒,什么也没介绍

认证主体太仓市沙溪镇牛文库商务信息咨询服务部
IP属地上海
统一社会信用代码/组织机构代码
92320585MA1WRHUU8N

1亿VIP精品文档

相关文档